Gyrus Capital Acquires 40% Stake in Consulcesi Group
December 1, 2022
Funds advised by Gyrus Capital have acquired a 40% stake in Consulcesi Group, with founder Massimo Tortorella and management remaining involved. The investment will support Consulcesi's international expansion and M&A-driven growth to build a pan‑European digital healthcare platform and target doubling revenue to over €120 million by 2025.
- Buyers
- Gyrus Capital, Massimo Tortorella and Consulcesi management (co-investors)
- Targets
- Consulcesi Group
- Industry
- Healthcare Services
- Location
- Ticino, Switzerland
- Transaction Type
- Growth capital
Explore More
Related Acquisitions
-
Gyrus Capital to acquire PwC Italia's Public Administration & Public Healthcare consulting business
June 4, 2021
Consulting
Gyrus Capital has agreed to acquire PwC Italia's consulting business that advises public administration and public healthcare systems on transformation, technology and project management. The carve-out—employing about 700 people—will be rebranded and remain led by the current management team, which will co-invest alongside Gyrus; the transaction was expected to close in Q3 2021. Gyrus intends to expand the team and product offering in Italy and internationally.
-
Gyrus Capital Acquires Majority Stake in Katalist Group
June 24, 2022
IT Services
Gyrus Capital has agreed with Katalist Group founders and management to acquire a majority stake in Katalist Group to build a global software integration platform serving food wholesalers/retailers and pharmacy companies. Katalist — a software implementation and consulting specialist with more than 300 employees operating across Europe, Asia and the Americas — will pursue growth through further acquisitions and integration of specialist software implementors.
-
Gyrus Capital Leads $68M Equity Investment in Neo Medical
September 17, 2024
Medical Devices
Swiss private equity firm Gyrus Capital led a strategic equity investment of up to $68 million (CHF 58 million) into Swiss medical-technology company Neo Medical SA, with participation from existing investors including Swisscom Ventures, Verve Ventures, 4FO and Credit Suisse Entrepreneur Capital as well as the founders. The financing will fund Neo Medical’s US expansion, deployment of new spine surgery products, and further development of its AI-driven augmented reality intraoperative platform ADVISE.
-
Consello Acquires Morpheus Risk
January 29, 2026
Consulting
Consello has acquired Morpheus Risk, a UK-based risk and threat assessment firm, and will integrate the team into a newly formed Consello Risk practice. The deal expands Consello's advisory capabilities with on-the-ground intelligence, investigations and operational risk mitigation expertise to support multinational clients amid rising geopolitical volatility.
-
Gyrus Capital Acquires Majority Stake in ACBC
April 17, 2025
Consulting
Gyrus Capital, a European investment firm, will acquire a majority stake in ACBC (Anything Can Be Changed), a Milan-based B Corp specializing in sustainable fashion R&D, product innovation and circular solutions. The investment will support ACBC's international expansion, service diversification and targeted acquisitions while the co-founders and management reinvest and remain involved.
-
Novacap Invests in Consilium Insurance
December 9, 2024
Insurance
Novacap, a North American private equity firm, has announced a partnership investment in Consilium Insurance, a Montreal-based property & casualty insurance brokerage founded in 2013. The investment makes Consilium the seventh platform company in Novacap's Financial Services I fund and is intended to accelerate growth and expand Consilium's operations across Canada and North America.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.